Cancer Supportive Drug Care Market, By Therapeutic Class (G-CSFS (Granulocyte Colony Stimulating Factor), ESAS (Erythropoiesis-Stimulating Agents), Antiemetics, Bisphosphonates, Opioids, NSAIDS (Nonsteroidal Anti-Inflammatory Drug), and Other), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2032

Supportive drugs are sometimes known as protective medications. They are intended to shield particular organs or cells from the harmful effects of cancer treatment. Some examples of drugs that help with cancer treatment are Dexrazoxane, Rasburicase, Amifostine, and Allopurinol.

Drugs used in cancer supportive care have a much larger market now that people are more aware of the side effects of long-term cancer therapy. The primary factor propelling the market's expansion is the increase in the number of individuals exhibiting symptoms and indicators of cancer, such as anemia, hair loss, vomiting, and nausea after treatment. Determining the patient age groups that require supportive medications most attracts substantial investment and will ultimately positively influence the expansion of the Cancer Supportive Market for Care Drugs